Xinyi Solar Executes HKD1.84 Million Share Buyback, Total Repurchases Reach 15 Million Shares

Bulletin Express10-15

Xinyi Solar Holdings Limited disclosed a Next Day Disclosure Return showing that it repurchased 1.00 million ordinary shares on 15 October 2026 via on-exchange transactions at a uniform price of HKD 1.835 per share. The transaction totaled HKD 1.84 million and represented 0.0109% of the company’s 9.13 billion issued shares prior to the buyback.

The repurchased shares are earmarked for cancellation. As at the reporting date, the issued share capital remained unchanged at 9.13 billion shares because the cancellation process had not yet been completed.

This latest transaction forms part of the share-repurchase mandate approved by shareholders on 29 May 2026, which authorises the company to buy back up to 914.70 million shares. Including the 1.00 million shares bought on 15 October, Xinyi Solar has repurchased an aggregate 15.00 million shares under the mandate, equal to 0.1639% of the shares outstanding on the mandate date.

Under Hong Kong listing rules, the company is subject to a 30-day moratorium—lasting until 15 November 2026—on issuing new shares or disposing of treasury shares following the buyback. The board confirmed that all repurchases were conducted in accordance with the Hong Kong Stock Exchange’s listing requirements and relevant legal regulations.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment